Healthcare | April 28, 2026
Rheumatology Awareness Walkathon 2026 spotlights arthritis and autoimmune care
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The early-stage study will test the drug’s safety, tolerability and biological effects in humans
The approval marks a major advance in targeted treatment for this rare, chronic autoimmune disease, offering twice-yearly maintenance dosing after two initial loading doses
MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Sun Pharma has been involved in a patent infringement case with Incyte Corporation over LEQSELVI
AbbVie receives the option to license worldwide rights to CUG252 from Cugene, a clinical-stage and potential best-in-class Treg-selective IL-2 mutein, building on AbbVie's commitment to developing novel therapies in immunology
Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
The approval was driven by data from the Phase III TULIP-SC trial
Subscribe To Our Newsletter & Stay Updated
